These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17125913)

  • 1. Cadmium induces mitogenic signaling in breast cancer cell by an ERalpha-dependent mechanism.
    Brama M; Gnessi L; Basciani S; Cerulli N; Politi L; Spera G; Mariani S; Cherubini S; Scotto d'Abusco A; Scandurra R; Migliaccio S
    Mol Cell Endocrinol; 2007 Jan; 264(1-2):102-8. PubMed ID: 17125913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
    Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidences for involvement of estrogen receptor induced ERK1/2 activation in ovarian cancer cell proliferation by Cadmium Chloride.
    Ataei N; Aghaei M; Panjehpour M
    Toxicol In Vitro; 2019 Apr; 56():184-193. PubMed ID: 30682495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor α attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors.
    Chang J; Sui M; Fan W
    Breast Cancer Res Treat; 2012 Aug; 134(3):969-80. PubMed ID: 22374518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hexachlorobenzene induces cell proliferation and IGF-I signaling pathway in an estrogen receptor alpha-dependent manner in MCF-7 breast cancer cell line.
    García MA; Peña D; Alvarez L; Cocca C; Pontillo C; Bergoc R; de Pisarev DK; Randi A
    Toxicol Lett; 2010 Feb; 192(2):195-205. PubMed ID: 19879930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes.
    Moggs JG; Murphy TC; Lim FL; Moore DJ; Stuckey R; Antrobus K; Kimber I; Orphanides G
    J Mol Endocrinol; 2005 Apr; 34(2):535-51. PubMed ID: 15821115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin inhibits both ER alpha activation and breast cancer cell proliferation induced by a metalloestrogen, cadmium.
    Martínez-Campa C; Alonso-González C; Mediavilla MD; Cos S; González A; Ramos S; Sánchez-Barceló EJ
    J Pineal Res; 2006 May; 40(4):291-6. PubMed ID: 16635015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metalloestrogenic effects of cadmium are absent in long-term estrogen-deprived MCF-7 cells: Evidence for the involvement of constitutively activated estrogen receptor α and very low expression of G protein-coupled estrogen receptor 1.
    Hirao-Suzuki M; Takeda S; Kodama Y; Takiguchi M; Toda A; Ohara M
    Toxicol Lett; 2020 Feb; 319():22-30. PubMed ID: 31689473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor DNA binding is not required for estrogen-induced breast cell growth.
    DeNardo DG; Cuba VL; Kim H; Wu K; Lee AV; Brown PH
    Mol Cell Endocrinol; 2007 Oct; 277(1-2):13-25. PubMed ID: 17825481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cadmium promotes breast cancer cell proliferation by potentiating the interaction between ERalpha and c-Jun.
    Siewit CL; Gengler B; Vegas E; Puckett R; Louie MC
    Mol Endocrinol; 2010 May; 24(5):981-92. PubMed ID: 20219890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells.
    Secreto FJ; Monroe DG; Dutta S; Ingle JN; Spelsberg TC
    J Cell Biochem; 2007 Aug; 101(5):1125-47. PubMed ID: 17520659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
    Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
    Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
    Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
    J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
    Jiang J; Slivova V; Sliva D
    Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor independent rapid non-genomic effects of environmental estrogens on [Ca2+]i in human breast cancer cells.
    Walsh DE; Dockery P; Doolan CM
    Mol Cell Endocrinol; 2005 Jan; 230(1-2):23-30. PubMed ID: 15664448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cadmium mimics estrogen-driven cell proliferation and prolactin secretion from anterior pituitary cells.
    Ronchetti SA; Miler EA; Duvilanski BH; Cabilla JP
    PLoS One; 2013; 8(11):e81101. PubMed ID: 24236210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogenic down-regulation of protein tyrosine phosphatase gamma (PTP gamma) in human breast is associated with estrogen receptor alpha.
    Liu S; Sugimoto Y; Kulp SK; Jiang J; Chang HL; Park KY; Kashida Y; Lin YC
    Anticancer Res; 2002; 22(6C):3917-23. PubMed ID: 12553013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
    Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
    J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.